KPC Pharmaceuticals Inc
SSE:600422
Wall Street
Price Targets
Price Targets Summary
KPC Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for KPC Pharmaceuticals Inc is 25.51 CNY with a low forecast of 24.44 CNY and a high forecast of 27.11 CNY.
Price Targets
Operating Income
Forecast
Operating Income Estimate
KPC Pharmaceuticals Inc
For the last 8 years the compound annual growth rate for KPC Pharmaceuticals Inc's operating income is 2%. The projected CAGR for the next 3 years is 24%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KPC Pharmaceuticals Inc's stock price target?
Price Target
25.51
CNY
According to Wall Street analysts, the average 1-year price target for KPC Pharmaceuticals Inc is 25.51 CNY with a low forecast of 24.44 CNY and a high forecast of 27.11 CNY.
What is KPC Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
13%
For the last 8 years the compound annual growth rate for KPC Pharmaceuticals Inc's revenue is 6%. The projected CAGR for the next 3 years is 13%.
What is KPC Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
24%
For the last 8 years the compound annual growth rate for KPC Pharmaceuticals Inc's operating income is 2%. The projected CAGR for the next 3 years is 24%.
What is KPC Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
29%
For the last 8 years the compound annual growth rate for KPC Pharmaceuticals Inc's net income is 1%. The projected CAGR for the next 3 years is 29%.